Vimian Group AB (CHIX:VIMIAS) FFO


CHIX:VIMIAS Vimian Group AB CHIX:VIMIAS
59 GF Score
Price kr30.28
GF Value kr31.92
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Vimian Group AB FFO?

FFO (Funds from operations) only applies to REITs.

CHIX:VIMIAS
59GF Score
Vimian Group AB CHIX:VIMIAS
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Vimian Group AB (CHIX:VIMIAS) Overvalued in 2026?

Based on GuruFocus' analysis, Vimian Group AB stock appears to be undervalued. The current stock price of kr30.28 is trading 5.2% below its estimated GF Value™ of kr31.92. GuruFocus considers Vimian Group AB to be Fairly Valued.

Key valuation signals for CHIX:VIMIAS:

  • FFO:
  • GF Value™: kr31.92 vs. price of kr30.28 (5.2% below fair value)
  • GF Score™: 59/100 with 2 warning signs

No single metric tells the full story. See the CHIX:VIMIAS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vimian Group AB Business Description

Other Exchanges VIMIAN:Sweden0V0:Germany
Address Riddargatan 19, Stockholm, SWE, SE-11457
Vimian Group AB specializes in the areas of animal health, such as specialty pharma, diagnostics, medtech, and veterinary services. It offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals, with a position within allergy, dermatology, otology, and specialized nutrition. Its geographical segments include Europe, North America, and the Rest of the world.
59GF Score

Get the complete analysis for CHIX:VIMIAS

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr30.28
Price
kr31.92
GF Value